Powered Surgical Instruments Market is increasing demand of Medical Device.

Over the past few years, the powered surgical instruments market has been witnessing continuous growth. Factors such as aging population, increasing volume of global surgical procedures and increasing demand for minimally invasive surgeries is fuelling market growth. The market has also witnessed transformative and innovative technological advancements, such as surgical robotics, that have positively impacted the market.

https://www.marketsandmarkets.com/pdfdownload.asp?id=239163256

This market is primarily driven by increased healthcare spending globally, rise in the prevalence of lifestyle diseases, increased accessibility to healthcare, and medical tourism.  However, inadequate quality assurance, lack of proper sterilization practices for equipment, and constant pressure on healthcare providers to reduce costs are restricting the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=239163256

There are several geographic drivers as well for the growth of the powered surgical instruments market. Asia-Pacific is gradually becoming a growth hub for this market. Factors such as the booming medical tourism industry, rising unmet healthcare needs and prevalence of chronic diseases that require surgical procedures are propelling the market growth in this region.

Request Sample: https://www.marketsandmarkets.com/requestsample.asp?id=239163256

The top six players in the global powered surgical instruments market accounted for more than 85% to 90% of the market share in 2014. However, new entrants in the market are intensifying competition and thereby threatening the market share of existing players. In order to maintain their share, leading players are continuously adopting new technologies and introducing new products into the market. This increasing competitiveness is expected to drive innovation in the market, thereby helping the industry to solve existing challenges and meet the needs of the market.

Scope of the Report

Powered surgical instruments are specially designed tools or devices that assist in the performance of various surgeries, including orthopedic surgery, ENT surgery, neurosurgery, and oral and maxillofacial surgery, among others. These are routinely used in many surgical procedures for several applications such as cutting, drilling, and sawing. Increasing R&D activities to develop innovative products and technologies are expected to boost the growth of the market.

Global Powered surgical instruments Market

This research report categorizes the powered surgical instruments market into the following segments:

Global Powered surgical instruments Market, By Power Source

• Electric Instruments
• Battery-powered Instruments
• Pneumatic Instruments

Global Powered surgical instruments Market, By Product

• Handpieces
  • Drills
  • Saws
  • Reamers
  • Staplers
  • Shavers
  • Wire/Pin Drivers
  • Others
• Power Source and Controls
  • Batteries
  • Electric Consoles
  • Pneumatic Regulators
• Accessories
  • Surgical Accessories
  • Electrical Accessories
  • Other Accessories

Hemostats Market worth 2.76 Billion USD by 2020

The report "Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020", The global hemostats market size is anticipated to reach USD 2.76 Billion by 2020, at a CAGR of 6.2% from 2015 to 2020. Factors such as increasing surgical procedures and rising number of insurance providers are driving the hemostats market. According to Center for Disease Control and Prevention (CDC), 51.4 Million surgeries have taken place in the U.S. in 2014. The increase in number of surgeries accelerates the demand for hemostats and thereby is driving the growth of the market. However, the high cost of products hinder the growth of the global hemostats market.

Browse 199 market data Tables and 90 Figures spread through 159 Pages and in-depth TOC on "Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/hemostats-market-9571619.html
Early buyers will receive 10% customization on reports.

Based on product type, the global hemostats market is segmented into thrombin-based, oxidized regenerated cellulose based hemostats, combination hemostats, gelatin based hemostats, and collagen based hemostats. The thrombin based hemostats segment dominates the hemostats market and is projected to grow at a significant pace during the forecast period, in terms of value.

Based on geography, the global hemostat market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. Each region is further segmented into countries, covering around 50 countries, globally. The market in the Americas is one of the key geographical segments that generates major revenue in the global hemostats market. The growth in the Americas hemostats market is attributed to the increase in number of surgical procedures. However, the hemostats market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.

Major companies operational in the hemostats market are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).

https://www.marketsandmarkets.com/pdfdownload.asp?id=9571619

The research study is aimed at identifying emerging trends and opportunities in the global hemostats market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hemostats market on the basis of product type and geography. Apart from the market segmentation, this report also provides an in-depth analysis of the market by providing a detailed process flow diagram and market dynamics, such as drivers, restraints, and opportunities in the global hemostats market.

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Patient Access Solutions Market worth 1.74 Billion USD by 2022

The report "Patient Access Solutions Market by Product & Service (Eligibility Verification, Medical Necessity, Prior-authorization, Denial Management), Delivery Mode (Web & Cloud, On-premise), End User (Providers, Outsourcing Companies) - Global Forecast to 2022", The patient access solutions market is expected to reach USD 1.74 Billion by 2022 from an estimated USD 1.21 Billion in 2017, at a CAGR of 7.6%. Regulatory compliance encouraging the use of patient access solutions, increasing patient volume and the subsequent growth in the demand for health insurance, growing importance of denial management, declining reimbursement rates, and need to curtail escalating healthcare costs are the major factors driving the growth of the patient access solutions market.

Browse 62 market data Tables and 34 Figures spread through 145 Pages and in-depth TOC on "Patient Access Solutions Market by Product & Service (Eligibility Verification, Medical Necessity, Prior-authorization, Denial Management), Delivery Mode (Web & Cloud, On-premise), End User (Providers, Outsourcing Companies) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/patient-access-solution-market-280473.html
Early buyers will receive 10% customization on reports.

“By product & service, the services segment accounted for the largest share of the patient access solutions market in 2016.”

On the basis of product & service, the services segment accounted for the largest share of the global patient access solutions market. The introduction of complex software and the need for system integration are expected to boost the services market in the near future.

“By delivery mode, the web & cloud-based solutions segment accounted for the largest share of the patient access solutions market in 2016.”

On the basis of delivery mode, the web & cloud-based solutions segment accounted for the largest share of the global patient access solutions market. This segment is also exected to grow at the highest CAGR during the forecast period. Factors such as flexibility of working from remote areas, rising affordability, and features such as auto-upgradation are attributing to the larger share and high growth of the web & cloud-based solutions segment.

“By end users, the healthcare providers segment held the largest market share of patient access solutions market in 2016.”

Based on end user, the healthcare providers segment accounted for the largest share of the patient access solutions market. Increasing healthcare IT adoption, increasing affordability in developing countries, and increasing volume of claims denials are the major factors supporting the adoption of patient access solutions in healthcare providers.

https://www.marketsandmarkets.com/pdfdownload.asp?id=280473

“North America dominated the market in 2016.”

North America accounted for the largest share of the patient access solutions market in 2016, followed by Europe and Asia Pacific. North America’s large share in the global market is attributed to factors such as ever-changing healthcare regulations, transition toward high co-pay by patients, increasing government support for improving healthcare IT infrastructure, increasing volume of claims denials, high number of private and government payers, and the presence of a large number of healthcare IT companies.

Prominent players in the patient access solutions market are McKesson (US), Epic Systems (US), Cerner (US), Cognizant (US), Experian (Ireland), Optum (US), Conifer Health (US), The Advisory Board (US), 3M (US), Craneware (UK), The SSI Group (US), ZirMed (US), Cirius Group (US), and AccuReg Software (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ Research Pvt. Ltd.
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013.
1-888-600-6441
Email: sales@marketsandmarkets.com

Optical Imaging Market by Applications, Technique, Product & Therapeutic Area - 2020

The report "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020", The Global Optical Imaging Market Is Expected to reach USD 1,749.2 Million by 2020. The market was valued at USD 989.0 Million in 2015 and is expected to grow at a CAGR of 12.1% from 2015 to 2020.

Browse 161 market data Tables and 43 Figures spread through 200 Pages and in-depth TOC on "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/optical-imaging-technologies-market-894.html
Early buyers will receive 10% customization on reports.

Owing to the technological advancements and increasing application areas of optical imaging techniques in pharmaceutical and biotechnological industries and medical diagnostics & therapeutics, the optical imaging market recorded a healthy growth rate during last decade. Optical imaging is extensively used for several applications including preclinical research, disease diagnosis, imaging of various cellular and molecular processes in vivo including protein interactions, protein degradation, and protease activity. Thus, increasing research activities in the biopharmaceutical industry and rising applications of optical imaging modalities for therapeutic and diagnostic purposes is expected to have a positive impact on the growth of this market. Moreover, uptake of optical imaging techniques due to growing demand for non-invasive & non-ionizing imaging modalities with ageing population and integration of optical imaging techniques with other imaging modalities is expected to drive the demand for optical imaging products in the coming years. However, high installation cost, complex regulatory requirements, and lack of skilled operators is likely to hinder the growth of the market to a certain extent.

In this report, the global optical imaging market is segmented by techniques, products, applications, end users, geographic regions, and countries. It also discusses the key market drivers, restraints, opportunities, trends, and challenges of this market and its sub-markets.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=894

In 2013, North America accounted for the largest share of the global optical imaging market, followed by Europe and Asia-Pacific. Greater uptake of optical imaging products and the presence of large number of optical imaging products manufacturers in the North American and European region has led to their large market share in the optical imaging market. However, the Asia-Pacific region represents the substantial growth opportunity for the optical imaging market during the forecast period of 2015 to 2020. The growth in this region is primarily driven by increased focus on healthcare growth in geriatric population, rising per capita income, increasing investments in the APAC healthcare industry by key market players, rising demand for cutting-edge technologies, and low labor costs.

Request Sample: https://www.marketsandmarkets.com/requestsample.asp?id=894

The prominent players in the optical imaging market include Carl Zeiss Meditec AG (Germany), Bioptigen, Inc. (U.S.), Topcon Medical Systems, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Canon, Inc. (U.S.), and PerkinElmer, Inc. (U.S.),

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

The neuromodulation market is segmented on the basis of technology, application, and region. The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players, and expanded target applications and new indications are driving the growth of this market. Moreover, expansion in emerging economies is likely to create significant growth opportunities for players operating in the neuromodulation market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals act as restraints hindering its market growth.

https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html

Some of the major players in the global neuromodulation market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).

https://www.marketsandmarkets.com/pdfdownload.asp?id=921

Scope of the Report:

This research report categorizes the neuromodulation market into the following segments and sub-segments:

Neuromodulation Market, by Technology

• Internal Neuromodulation
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
• External Neuromodulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Respiratory Electrical Stimulation

Neuromodulation Market, by Application

• Spinal Cord Stimulation
  • Chronic Pain
  • Failed Back Surgery
  • Ischemia
• Deep Brain Stimulation
  • Parkinson's disease
  • Tremor
  • Depression
  • Others ( Alzheimer's disease, Dystonia, Tourette syndrome)
• Sacral Nerve Stimulation
  • Urine Incontinence
  • Fecal Incontinence
• Vagus Nerve Stimulation Market
  • Epilepsy

Others (Heart failure, Tinnitus)

• Gastric Electrical Stimulation
  • Gastroparesis
  • Obesity
• Transcranial Magnetic Stimulation
  • Depression
  • Migraine headaches
• Transcutaneous Electrical Nerve Stimulation
  • Treatment Resistant Depression
  • Others ( Stroke, Tinnitus)

Neuromodulation Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Rest of Europe (RoE)
• Asia
  • China
  • Japan
  • India
  • Rest of Asia (RoA)
• Rest of the World (RoW)

Health IT Security Market Worth 9,867.5 Million USD by 2020

According to a new market research report "Health IT Security Market Products and Services (Products (Antivirus, IAM, DLP), Services (Consulting, MSS)), Application (Network Security, Endpoint Security), Delivery Mode (On-premise, On-demand), End User (Provider, Payer) - Global Forecast to 2020", published by MarketsandMarkets, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

Browse 159 market data tables and 41 figures spread through 182 pages and in-depth TOC on "Health IT Security Market "

https://www.marketsandmarkets.com/Market-Reports/healthcare-it-252.html

Early buyers will receive 10% customization on this report. 

The health IT security market is expected to witness high growth in coming years. The market size, in terms of value, is expected to reach USD 9,867.5 Million by 2020 from USD 4,905.9 Million in 2015, at a CAGR of 15.0%.

For further Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=252

Health IT security Market is segmented on the basis of products and services, applications, delivery mode, end user, and region. The Health IT security market, by end user, is segmented into healthcare providers and payers. The providers market is further segmented into hospitals, physician practices, and others. The primary driver for the growth of the market is the threat of data breach; in 2014, according to industry experts, data breach incidents among healthcare payers and providers increased dramatically by 55%-60% from 2013. This has highlighted the need to deploy IT security measures.

Geographically, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is further sub-segmented into the U.S. and Canada; while, Europe is further sub-segmented into Germany, the U.K., France, and Rest of Europe (RoE). North America is estimated to account for the largest share of the Health IT security market in 2015 and Asia poised to be the fastest-growing region during the forecast period.

The Health IT Security Market is highly fragmented. Some of the key players in this market includes IBM Corporation (U.S.), Intel Corporation (U.S.), Symantec (U.S.), EMC Corporation (U.S.), Trend Micro (Japan), Oracle Corporation (U.S.), SailPoint Technologies (U.S.), Hewlett Packard (U.S.), Dell, Inc. (U.S.), CA Technologies (U.S.), PricewaterhouseCoopers (PwC) (U.S.), Verizon (U.S.), AT&T (U.S.), Wipro (India), Okta, Inc. (U.S.), CyberArk (U.S.), and CenturyLink (Savvis) (U.S.).

Browse Related Reports: 

Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, mHealth, Telehealth, Healthcare analytics, Supply Chain Management, Revenue Cycle Management, CRM, Claims Management, Fraud Management) by End User (Provider, Payer ) - Global Forecast to 2020

http://www.marketsandmarkets.com/Market-Reports/healthcare-it-252.html

Healthcare Analytics/Medical Analytics Market by Application (Clinical, PHM, Financial (RCM, Claim & Fraud), Supply Chain & HR), Type (Predictive), Delivery model (On-premise, Cloud), End-user (Payer, Hospital, Ambulatory, ACO) - Global Forecast to 2020

http://www.marketsandmarkets.com/Market-Reports/healthcare-data-analytics-market-905.html

About MarketsandMarkets  

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Drug Discovery Informatics Market worth 2.84 Billion USD by 2022

The report "Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022", The global drug discovery informatics market is expected to reach USD 2.84 Billion from USD 1.67 Billion at a CAGR of 11.2%. Rising R&D expenditure and increasing focus on drug discovery are the major factors driving the adoption of discovery informatics solutions.

Browse 63 market data Tables and 24 Figures spread through 115 Pages and in-depth TOC on "Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/drug-discovery-informatics-market-64537381.html
Early buyers will receive 10% customization on reports.

Based on function, the sequencing and target data analysis segment is accounted for the largest share of the market in 2017

On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.

Based on solution, the software segment is accounted for the largest share of the market in 2017

The solution segment of the drug discovery informatics market is divided into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The dominant share of this market is attributed to the fact that drug discovery informatics software solutions enable the fast and efficient management of data generated throughout the drug discovery process.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=64537381

North America is expected to dominate the market in 2017

The North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market.

The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Medical Automation Market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

Emerging Asia-Pacific countries, including India and China, offer high growth potential for companies engaged in the development and marketing of automated solutions for the healthcare industry. Growing geriatric population; increasing cases of cardiovascular disease (CVD), diabetes, cancer, and orthopedic diseases; rising clinical research; and growing government expenditure on healthcare and life science research are the key factors propelling the growth of the medical automation market in the emerging countries.

On the basis of application, the medical automation market is divided into four segments, namely, diagnostic and monitoring automation (automated image analysis, automated imaging, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and training (logistic automation and trainers). The medical logistics and training segment is expected to grow at the highest rate in the next five years, owing to high adoption of these automated systems (pneumatic tubes, AGV, RTLS, and RFID) by big hospitals and diagnostic centers.

The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

The therapeutic automation market segment holds the largest share in the global medical automation market. This segment is further categorized on the basis of product into non-surgical automation (defibrillators and automated medication systems) and surgical automation (surgical robots, intraoperative imaging, surgical navigation, intelligent operating rooms, and surgical simulators). In 2015, the non-surgical automation segment held a larger share of 72.9% of the global therapeutic automation market. The increasing incidences of various chronic diseases and technological advancements in defibrillators and medication systems are the key factors contributing to the growth of this market segment.

The global medical automation market is divided into four segments on the basis of end users– hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.

The global medical automation market is estimated to grow at a CAGR of 9.5% from 2015 to 2020. A number of factors such as continuous advancements in various medical automation technologies; increasing government financial support for medical automation; and growing adoption of automation in laboratory, pharmacy, and medical logistics operations are propelling the growth of the global medical automation market. However, high cost of automation and stringency of regulatory procedures leading to delayed product launches are the key factors restraining the growth of this market.

On the basis of geography, medical automation  market is classified into four regions, namely, North America (U.S. and Canada), Europe, Asia-Pacific, and the Rest of the World. In 2015, the global medical automation market is estimated to be dominated by North America. Large number of ongoing clinical trials in the U.S., high adoption rate of technologically advanced medical devices in this region, and developed healthcare reimbursement structure are contributing to the large share of the North American medical automation market. The Asia-Pacific market is expected to grow at the highest CAGR from 2015 to 2020. Factors such as growing government expenditure on healthcare research, rising number of clinical research activities owing to increasing R&D outsourcing to developing Asian countries, increasing old age population and associated diseases, availability of a large patient pool, and developing healthcare infrastructure are propelling the growth of the Asia-Pacific medical automation market.

http://www.marketsandmarkets.com/Market-Reports/medical-automation-technologies-market-848.html

New product launches, product approvals, and product enhancements is the primary growth strategy adopted by major players to enhance their positions in the global medical automation market. Moreover, strategies such as partnerships, agreements, and collaborations; geographic expansions; and acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the market.

Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), General Electric Company (U.S.), Intuitive Surgical, Inc. (U.S.), Medtronic plc (U.S.), Tecan Group Ltd. (Switzerland), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland) are some of the key players operating in the global medical automation market.

Download PDF Brochure:  http://www.marketsandmarkets.com/pdfdownload.asp?id=848

Scope of the Report

This research report categorizes the global medical automation market into the following segments:

Global Diagnostics and Monitoring Automation Market

• Automated Imaging
  • Automated Fluoroscopy
  • Automated Radiography
  • Automated Microscopy
  • Capsule Endoscopy
• Point-of-care Testing (POCT)
• Automated Image Analysis

Global Therapeutic Automation Market

• Non-surgical Automation Market
  • Defibrillators
    • Implantable Cardioverter Defibrillators
    • Automated External (Portable) Defibrillators
    • Wearable Defibrillators
    • Automated Medication Delivery Systems
      • Implantable Drug Pumps
      • Wearable Drug Pumps
• Surgical Automation Market
  • Surgical Robots
    • da Vinci
    • CyberKnife
    • RIO
    • Renaissance
  • Intelligent Operating Rooms
  • Intraoperative Imaging
    • Intraoperative Ultrasound
    • Intraoperative CT
    • Intraoperative MRI
  • Surgical Navigation Systems
  • Surgical Simulators

Global Pharmacy and Laboratory Automation Market

• Laboratory Automation Market
  • Automated Liquid Handling
  • Microplate Readers
  • Software & Informatics
  • Standalone Robots
  • Automated Storage & Retrieval Systems (ASRS)
• Pharmacy Automation Market
  • Automated Medication Dispensing Systems
  • Automated Packaging and Labeling Systems
  • Automated Medication Compounding Systems

Global Medical Logistics & Training Automation Market

• Logistics Automation
  • Hospital Asset/Patient/Staff Tracking Systems Market
    • Radiofrequency Identification
    • Real-time Location Systems (RTLS)
  • Automated Hospital Pickup & Delivery
    • Pneumatic Tube Systems (PTS)
    • Automated Guided Vehicles (AGV)
• Trainers

Global Medical Automation Market, by End User

• Hospitals & Diagnostic Centers
• Research Laboratories & Institutes
• Pharmacies
• Home/Ambulatory Care Settings & Others

Global Medical Automation Market, by Region

• North America
  • U.S.
  • Canada
• Europe
• Asia-Pacific
• Rest of the World

Referral Management Market worth $2686.3 Million by 2019

The “Referral Management Market by Type (Self-referral, Professional-referral, & Third party-referral), Component (Software, & Services), Delivery Mode (On-Premise, Web, & Cloud), End-user (Provider, Payer) - Trend & Global Forecast to 2019”, analyzes and studies the major market drivers, restraints, and opportunities, in North America, Europe, Asia, and Rest of the World (RoW).

                  

Browse 76 market data tables and 49 figures spread through 154 pages and in-depth TOC on “Referral Management Market by Type (Self-referral, Professional-referral, & Third party-referral), Component (Software, & Services), Delivery Mode (On-Premise, Web, & Cloud), End-user (Provider, Payer) - Trend & Global Forecast to 2019"
https://www.marketsandmarkets.com/Market-Reports/referral-management-market-196292082.html
Early buyers will receive 10% customization on reports.

This report studies the global referral management market over the forecast period of 2014 to 2019. This market was valued at $988 million in 2014 and is poised to grow at a CAGR of 22.1% from 2014 to 2019, to reach $2,686.3 million by 2019.

The referral management market is segmented on the basis of type, component, delivery mode, end user, and region. The market, by type, is categorized into self-referrals, professional referrals, and third-party referrals. By component, the market is divided into software and services. Based on delivery mode, the market is categorized into web-based, on-premise, and cloud-based. The market by end user is categorized into providers, payers, patients, and others. Based on region, the market is divided into North America, Europe, Asia, and the Rest of the World (Pacific, the Middle East & Africa, and Latin America).

The major factors driving the growth of the referral management solutions market are increasing government initiatives to incorporate IT solutions in healthcare globally, rise in aging population and incidence of chronic disease, the benefits of referral management solutions, and the shortage of nursing staff and doctors. However, despite the benefits of referral management solutions, certain barriers such as the failure to reduce outpatient attendance, lack of skilled healthcare IT professionals, and security concerns are restraining the growth of this market.

In 2014, the North American market commanded the largest share of the global referral management market, followed by Europe and Asia. Asia is the fastest-growing region in this market. Although the Asian segment is relatively new in the referral management market, the increasing HCIT adoption, proficiency of IT skills, and the growing healthcare expenditure in countries like India will drive the growth of this market in Asia.

The major players in the global referral management market include Allscripts Healthcare Solutions, Inc. (U.S.), Cerner Corporation (U.S.), McKesson Corporation (U.S.), ReferralMD (U.S.), Harris Corporation (U.S.), The Advisory Board Company (U.S.), ehealth Technologies (U.S), Eceptionist, Inc. (U.S.), Clarity Health (U.S.), and Kyruus, Inc. (U.S.)

Drug Discovery Informatics Market worth 2.84 Billion USD by 2022

The report "Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022", The global drug discovery informatics market is expected to reach USD 2.84 Billion from USD 1.67 Billion at a CAGR of 11.2%. Rising R&D expenditure and increasing focus on drug discovery are the major factors driving the adoption of discovery informatics solutions.

Browse 63 market data Tables and 24 Figures spread through 115 Pages and in-depth TOC on "Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/drug-discovery-informatics-market-64537381.html
Early buyers will receive 10% customization on reports.

Based on function, the sequencing and target data analysis segment is accounted for the largest share of the market in 2017

On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.

Based on solution, the software segment is accounted for the largest share of the market in 2017

The solution segment of the drug discovery informatics market is divided into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The dominant share of this market is attributed to the fact that drug discovery informatics software solutions enable the fast and efficient management of data generated throughout the drug discovery process.

North America is expected to dominate the market in 2017

The North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market.

The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021

The global vaccine adjuvants market consists of human and veterinary adjuvants that are used to improve the efficacy of vaccines. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on prevention of diseases. The high growth potential in emerging markets has opened an array of opportunities for the market. However, the high cost of adjuvant-based research and proven safety of adjuvants are hampering the growth of the global market.

https://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

The vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5%. This market is segmented based on product type, route of administration, disease type, applications, and application category.

On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants. The particulate adjuvants segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. High prevalence of infectious diseases and increasing funding for adjuvant research will drive the growth of this market segment.

Based on route of administration, the vaccine adjuvants market includes oral route, subcutaneous route, intranasal route, intramuscular route, intradermal route, and other routes. The intramuscular segment is expected to account for the largest share of the global market in 2016. Rising geriatric population and vaccines for improved immunization are the key factors propelling the growth of this market.

Based on disease type, the vaccine adjuvants market comprises of infectious diseases, cancer, and other diseases. The infectious diseases segment is expected to account for the largest share of the global market in 2016. High prevalence of infectious diseases and cancer is expected to drive market growth in the coming years.

Based on applications, the vaccine adjuvants market is segmented into research applications and commercial applications. The research applications segment is expected to account for the largest share of the market during the forecast period. The large share of this segment can be attributed to factors such as ongoing research on new adjuvants, increasing initiatives by government bodies and companies, usage of many vaccine adjuvants commercially, increasing incidences of zoonotic diseases, and increase in the number of conferences and summits.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=152603894

Based on application categories, the vaccine adjuvants market is segmented into human and veterinary adjuvants. The human vaccine adjuvants segment is expected to account for the largest share of the global market in 2016 and is expected to have a higher growth rate in the application category segment. The large share of this segment can be attributed to the increasing initiatives by companies, vaccine adjuvants discovery and development, and increase in the number of conferences and summits.

Based on geography, the global vaccine adjuvants market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is expected to witness the highest CAGR, with the growth in this market centered at China and India. Rising prevalence of infectious diseases, increasing government investments for vaccine research and development, rising number of conferences and symposiums, and high growth in the Indian biotechnology sector are the major factors driving the market in the Asian region.

The major players in the vaccine adjuvants market are Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Protein Engineering Market worth $1,463.0 Million by 2020

The protein engineering market is expected to grow at a double–digit CAGR of 15.7% to reach $1,463.0 million by 2020 from $705.5 million in 2015. Major factors fueling market growth are the increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering, and reduction in overall timeline and cost for drug discovery. However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are restricting the growth of the market.

https://www.marketsandmarkets.com/Market-Reports/protein-antibody-engineering-market-898.html

This market is broadly segmented into instrument, reagent and services and software, by product. On the basis of technology the market is segmented into rational protein design, and irrational protein design. Rational protein design emerged as highly adopted technology in protein engineering market in 2014.

Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market.

Based on end user, the protein engineering market is broadly classified into academic research institutes, pharmaceutical and biotechnology companies and contract research organizations. Pharmaceutical and biotechnology companies is the largest and fastest-growing end user segment. The high growth rate of this market can be attributed to technological advancements in protein engineering and the increase in R&D budgets in the pharmaceutical sector.

Geographically, this market is dominated by North America, followed by Europe. Asia is expected to be the fastest growing region during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=898

Key players operating in this market are AB-Sciex (U.S.),  Agilent Technologies (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), , GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).

Atherectomy Devices Market by Type, Application & End User - 2022

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

https://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html

This report broadly segments the atherectomy devices market into product, application, end user, and region. On the basis of product, the market is categorized into directional, photo-ablative (laser), orbital, rotational atherectomy systems, and support devices. In 2017, the directional atherectomy devices segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technology advancements in the field of directional atherectomy.

Based on application, the atherectomy devices market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the largest share of the market and is expected to be the fastest growing segment during the forecast period. The large share of this segment is attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment and rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=133112140

Based on end user, the atherectomy devices market is segmented into three categories, namely, hospitals and surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment accounted for the largest share of the market due to the increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment and growing availability of healthcare reimbursements across major countries.

This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.

Factors such as stringent regulatory framework, significant adoption of alternative therapies, and dearth of well-trained surgeons to conduct atherectomy procedures are expected to restrain the growth of the atherectomy devices market during the forecast period.

The major players in the atherectomy devices market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).